VHFC researchers at Tulane University have published findings in the Journal of Virology on an antiviral peptide with potential implications for Lassa fever (LF) treatment. Unlike ribavirin, the only drug currently used to treat LF, the peptide is not acutely toxic, and its activity is highly specific against arenaviruses.
VHFC researchers publish promising results from a five-year Lassa Fever trial conducted in post-conflict Sierra Leone. The trial demonstrated the ability of a rapid diagnostic test, developed by Corgenix Medical and other members of the Consortium, to quickly detect Lassa virus.
KENEMA, Sierra Leone – March 27, 2014 – A Viral Hemorrhagic Fever Consortium (VHFC) team is assembling in Sierra Leone to respond to the ongoing Ebola outbreak in neighboring Guinea. The Ministry of Health in Guinea has most recently reported a total of 103 suspected cases and 66 deaths mostly in the areas of southeastern Guinea.
An outbreak of the deadly Ebola virus in West Africa has prompted Corgenix Medical Corporation (OTCBB:CONX) to extend its existing viral hemorrhagic fever (VHF) rapid test development to include the Ebola virus. Corgenix has already developed and CE marked a rapid test for the Lassa fever virus, another member of the VHF group of viruses.
Professor Erica Ollmann Saphire's group at the Scripps Research Institute in La Jolla California has published ground-breaking research into the mechanisms behind how the Ebola virus replicates and spreads.
Scientists from Tulane and Harvard University took part in the 2013 ASM Biodefense and Emerging Diseases Research Meeting held on February 25-27 in Washington D.C. The event featured talks by Dr. Jennifer Spence (School of Medicine, Tulane University) and Dr.
In an article published in The Guardian, VHFC Scientist Dr. Lina Moses discusses her research into the Mastomys rodents that transmit Lassa fever and how novel approaches to rodent control are being used to combat the disease on a local level.
A recent article in U-T San Diego features structural biologist and VHFC researcher Erica Ollmann Saphire. The article discusses her career path and research into the structures of virus-related proteins such as Lassa and Ebola.
VHFC scientists were able to locate three persons who worked in Nigeria dating back to the 1940s, two of whom were integrally involved in the early outbreaks and investigations of Lassa fever in the late 1960s, including the person from whom Lassa virus was first isolated.